Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VSV-GP154 |
Trade Name | |
Synonyms | VSV GP154|VSVGP154 |
Drug Descriptions |
VSV-GP154 is a vesicular stomatitis virus (VSV) viral vector-based cancer vaccine containing pancreatic adenocarcinoma patient-derived tumor-associated antigen peptides, which preferentially replicates in tumor cells expressing KRAS G12V or KRAS G12D, potentially resulting in tumor cell killing (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C199669 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ATP150 + ATP152 + Ezabenlimab + VSV-GP154 | ATP150 ATP152 Ezabenlimab VSV-GP154 | 0 | 1 |
ATP150 + ATP152 + VSV-GP154 | ATP150 ATP152 VSV-GP154 | 0 | 1 |
VSV-GP154 | VSV-GP154 | 0 | 0 |